Accessing Advanced Therapies (biologics, biosimilars, oral JAK inhibitors)
For some time, NRAS has been concerned that some Clinical Commissioning Groups (CCGs) have been artificially restricting access to advanced therapies (biologics, biosimilars/JAK inhibitors) and undertook a Freedom of Information request to all CCGs about this. Following discussions with NHS England on behalf of RA patients about this practice, which was felt to be unethical, NRAS is delighted to share with you news of the attached recently published statement from the NHS Regional Medicines Optimisation Committee.…
Read more of this article
The final version of the
The Institute of Osteopathy has recently published additional reports, including the impact of Multidisciplinary management of low back pain and sciatica in primary care. This impact report provides an overview of the Plymouth Community Back Pain Service which has delivered a sustainable primary care service with measurable outcomes run by a multidisciplinary team including GPs, osteopaths, cognitive behavioural therapists and physiotherapists.
As detailed in their latest e-news bulletin, this February HMSA will be involved in Marfan Awareness, Raynaud’s Awareness, and at the end of the month,

Two new outputs have been published by the Q Lab and Mind on improving care for people living with both mental and physical health problems:
by Sue Brown, CEO ARMA 